Paragraf – Parkwalk and UCEF V investment
We are delighted to announce that the University of Cambridge Enterprise Fund V and the Parkwalk Opportunities Fund have invested in £2.64m seed financing round in Paragraf, a spin-out from the University of Cambridge. Paragraf is aiming to… Read More
PsyOmics – follow-on investment
We are delighted to announce that the University of Cambridge Enterprise Fund V and the Parkwalk Opportunities Fund have invested in a follow-on financing round in PsyOmics, a spin-out from the Department of Chemical Engineering and Biotechnology. The… Read More
Horizon Discovery – Parkwalk UCEF I exit
We are delighted to have generated a 2.36x return (3.37x inclusive of initial tax reliefs) for our investors on the sale of the University of Cambridge Enterprise Fund I holding in Horizon Discovery plc. The investment was held for… Read More
Predictimmune – Parkwalk closes investment
We are delighted to announce that the Parkwalk Opportunities Fund and the University of Cambridge Enterprise Fund IV have completed an investment in Predictimmune Limited, a spinout company from the University of Cambridge.
Parkwalk closes PhoreMost follow-on investment
We are pleased to announce that Parkwalk has made an investment in Phoremost, a Cambridge University spinout, as part of a Series ‘B’ round of equity funding, alongside Amadeus Capital Partners and the University. Phoremost’s mission is to accelerate,… Read More
8power – Joins the LoRa Alliance™
8power is pleased to announce membership of the LoRa Alliance™, a global industry group to promote the development and deployment of the LoRaWAN™ Low Power Wide Area Network (LPWAN) open standard. The Alliance represents many of the leading… Read More
Congenica – Parkwalk closes investment
We are delighted to announce that the Parkwalk Opportunities Fund and the Parkwalk Technology Fund VII have invested in a $10m Series ‘B’ financing round for Congenica Limited, which spun out of the Wellcome Trust Sanger Institute and Department… Read More
Sphere Fluidics – Parkwalk closes further funding round
We have closed a follow-on investment in Sphere Fluidics for the Opportunities Fund. This follows the UCEFs investing previously. Sphere Fluidics is an established Life Sciences company which has developed unique products for use in single cell analysis and characterisation and provides collaborative R&D… Read More
Focal Point Positioning – University of Cambridge Enterprise Fund IV investment
Focal Point was founded in June 2015 with Dr Ramsey Faragher as CEO and CTO. The team had originally worked on a range of platforms seeking to improve the navigational and positioning systems on vehicles as diverse as submarines… Read More
Polypharmakos – University of Cambridge Enterprise Fund IV investment
Cambridge and Kew join forces to find new antimicrobial substances in plants The Parkwalk-mamanged University of Cambridge Enterprise Fund IV and Cambridge Enterprise have invested £500k in Polypharmakos Limited, a spin-out from the University of Cambridge and the… Read More
Cytora – Parkwalk closes follow-on Investment
We are pleased to announce that the University of Cambridge Enterprise Fund IV and the Parkwalk Opportunities Fund have closed an investment into Cytora, a geopolitical risk analytics spin-out from the University of Cambridge. Cytora is a pioneer in… Read More
Cambridge Touch Technologies – follow-on investment
We have recently made a follow-on investment in Cambridge Touch Technologies for the University of Cambridge Enterprise Fund IV, the Parkwalk UK Tech Fund VII and the Parkwalk Opportunities Fund in a series ‘A’ financing round. Cambridge Touch Technologies… Read More
Horizon Discovery – Strong Revenue Growth and Focus on Operational Gearing Underpin Path to Profitability
Cambridge, UK, 20 September 2016: Horizon Discovery Group plc (LSE: HZD), a world leader in the application of gene editing technologies, announces its interim results for the six months ended 30 June 2016. Highlights (including post period end):… Read More
Healthera – University of Cambridge Enterprise Fund III investment
We are delighted to announce that the University of Cambridge Enterprise Fund III has invested in Healthera Ltd, a provider of next-generation, pharmacy-integrated personal health management solutions, has secured seed investment from the University of Cambridge, the University of… Read More
PervasID – University of Cambridge Enterprise Fund IV investment
We are delighted to announce that the University of Cambridge Enterprise Fund IV, managed by Parkwalk, has invested in PervasID, a spin-out from the Department of Engineering. The company has developed a long-range passive Radio-Frequency Identification (RFID) tracking… Read More
Fluidic Analytics – University of Cambridge Enterprise Fund IV and Parkwalk investment
Parkwalk have recently closed an investment in Fluidic Analytics for the University of Cambridge Enterprise Fund IV and Parkwalk Funds. Fluidic Analytics is developing a line of tools for the rapid, accurate, cost-effective analysis of proteins and other biomolecular species. By… Read More
PsyOmics – University of Cambridge Enterprise Fund IV investment
We are delighted to announce that the University of Cambridge Enterprise Fund IV, managed by Parkwalk, has invested in PsyOmics, a spin-out from the Department of Chemical Engineering and Biotechnology. The company aims to utilise blood-based diagnostics to… Read More
8Power – University of Cambridge Enterprise Fund III investment
We have recently made an investment in 8Power for the University of Cambridge Enterprise Fund III in a financing round. 8power Limited, a new company spun out of the University of Cambridge to develop and commercialise novel technology for… Read More
ARM Holdings – £24.3bn acquisition of the University of Cambridge spin-out
Japan’s Softbank on Monday offered £24.3bn ($32bn) in cash to acquire 100% of ARM Holdings, the UK’s smartphone chip designer that is one of the leaders in the infrastructure of the internet of things. In 2015, Forbes ranked… Read More
Posted on July 18, 2016
Electronics, Fund Managers Comments, Semiconductors
Cambridge, Electronics, Semiconductors